• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰岛素原对内皮细胞中I型纤溶酶原激活物抑制剂表达的刺激作用。

Stimulation by proinsulin of expression of plasminogen activator inhibitor type-I in endothelial cells.

作者信息

Schneider D J, Nordt T K, Sobel B E

机构信息

Cardiovascular Division, Washington University School of Medicine, St. Louis, Missouri 63110.

出版信息

Diabetes. 1992 Jul;41(7):890-5. doi: 10.2337/diab.41.7.890.

DOI:10.2337/diab.41.7.890
PMID:1612205
Abstract

In patients with non-insulin-dependent diabetes mellitus, concentrations in plasma of insulin and its precursors, proinsulin and split proinsulin, are increased. Because increased concentrations of plasminogen activator inhibitor type-1 (PAI-1) occur also, we hypothesized that proinsulin and split proinsulin may augment endothelial cell PAI-1 expression, thereby potentially attenuating endogenous fibrinolysis and accelerating atherosclerosis. Proinsulin increased PAI-1 activity in conditioned media of endothelial cells as did split proinsulin, paralleled by increased expression of PAI-1 mRNA. These effects of proinsulin were not dependent on its conversion to insulin nor on its interactions with the insulin receptor. The proinsulin stimulation of PAI-1 expression was not attenuated by either anti-insulin receptor antibodies or a 100-fold excess of insulin. Furthermore, proinsulin-mediated increases in PAI-1 expression were not inhibited by a 500-fold excess of insulinlike growth factor I. In addition, inhibition of tyrosine kinase, which mediates many of the diverse effects of insulin and insulinlike growth factor I, did not attenuate the effect of proinsulin. These results indicate that proinsulin augments PAI-1 expression, potentially contributing to vasculopathy in patients with non-insulin-dependent diabetes mellitus.

摘要

在非胰岛素依赖型糖尿病患者中,血浆中胰岛素及其前体(胰岛素原和裂解胰岛素原)的浓度会升高。由于纤溶酶原激活物抑制剂-1(PAI-1)的浓度也会升高,我们推测胰岛素原和裂解胰岛素原可能会增强内皮细胞PAI-1的表达,从而可能减弱内源性纤维蛋白溶解并加速动脉粥样硬化。胰岛素原和裂解胰岛素原一样,均可增加内皮细胞条件培养基中的PAI-1活性,同时PAI-1 mRNA的表达也会增加。胰岛素原的这些作用既不依赖于其转化为胰岛素,也不依赖于其与胰岛素受体的相互作用。胰岛素原对PAI-1表达的刺激作用既不会被抗胰岛素受体抗体减弱,也不会被100倍过量的胰岛素减弱。此外,500倍过量的胰岛素样生长因子I也不会抑制胰岛素原介导的PAI-1表达增加。另外,介导胰岛素和胰岛素样生长因子I多种不同作用的酪氨酸激酶的抑制作用,也不会减弱胰岛素原的作用。这些结果表明,胰岛素原会增强PAI-1的表达,这可能是导致非胰岛素依赖型糖尿病患者血管病变的原因之一。

相似文献

1
Stimulation by proinsulin of expression of plasminogen activator inhibitor type-I in endothelial cells.胰岛素原对内皮细胞中I型纤溶酶原激活物抑制剂表达的刺激作用。
Diabetes. 1992 Jul;41(7):890-5. doi: 10.2337/diab.41.7.890.
2
Augmentation of the synthesis of plasminogen activator inhibitor type-1 by precursors of insulin. A potential risk factor for vascular disease.胰岛素前体增强1型纤溶酶原激活物抑制剂的合成。血管疾病的一个潜在危险因素。
Circulation. 1994 Jan;89(1):321-30. doi: 10.1161/01.cir.89.1.321.
3
Augmentation of arterial endothelial cell expression of the plasminogen activator inhibitor type-1 (PAI-1) gene by proinsulin and insulin in vivo.
J Mol Cell Cardiol. 1998 Aug;30(8):1535-43. doi: 10.1006/jmcc.1998.0719.
4
Attenuation by gemfibrozil of expression of plasminogen activator inhibitor type 1 induced by insulin and its precursors.
Circulation. 1997 Feb 4;95(3):677-83. doi: 10.1161/01.cir.95.3.677.
5
Augmentation of synthesis of plasminogen activator inhibitor type 1 by insulin and insulin-like growth factor type I: implications for vascular disease in hyperinsulinemic states.胰岛素和胰岛素样生长因子I对1型纤溶酶原激活物抑制剂合成的增强作用:对高胰岛素血症状态下血管疾病的影响。
Proc Natl Acad Sci U S A. 1991 Nov 15;88(22):9959-63. doi: 10.1073/pnas.88.22.9959.
6
Induction of plasminogen activator inhibitor type-1 (PAI-1) by proinsulin and insulin in vivo.胰岛素原和胰岛素在体内对1型纤溶酶原激活物抑制剂(PAI-1)的诱导作用。
Circulation. 1995 Feb 1;91(3):764-70. doi: 10.1161/01.cir.91.3.764.
7
Stimulation in vivo of expression of intra-abdominal adipose tissue plasminogen activator inhibitor Type I by proinsulin.
Diabetologia. 2001 Sep;44(9):1121-4. doi: 10.1007/s001250100618.
8
SPARC induces the expression of type 1 plasminogen activator inhibitor in cultured bovine aortic endothelial cells.SPARC可诱导培养的牛主动脉内皮细胞中1型纤溶酶原激活物抑制剂的表达。
J Biol Chem. 1991 Jul 15;266(20):13178-84.
9
Augmentation of synthesis of plasminogen activator inhibitor type-1 in arterial endothelial cells by glucose and its implications for local fibrinolysis.葡萄糖对动脉内皮细胞中1型纤溶酶原激活物抑制剂合成的增强作用及其对局部纤溶的影响。
Arterioscler Thromb. 1993 Dec;13(12):1822-8. doi: 10.1161/01.atv.13.12.1822.
10
Induction of synthesis of plasminogen activator inhibitor type-1 by tissue-type plasminogen activator in human hepatic and endothelial cells.组织型纤溶酶原激活物在人肝细胞和内皮细胞中诱导1型纤溶酶原激活物抑制剂的合成。
Thromb Haemost. 1990 Nov 30;64(3):412-9.

引用本文的文献

1
Circadian rhythm of plasminogen activator inhibitor-1 and cardiovascular complications in type 2 diabetes.2 型糖尿病中纤溶酶原激活物抑制剂-1 的昼夜节律与心血管并发症。
Front Endocrinol (Lausanne). 2023 Mar 20;14:1124353. doi: 10.3389/fendo.2023.1124353. eCollection 2023.
2
Clinical and Laboratory Evaluation of a New Specific Point-of-Care Test for Intact Proinsulin.一种新型完整胰岛素原即时检验的临床与实验室评估
J Diabetes Sci Technol. 2017 Mar;11(2):278-283. doi: 10.1177/1932296816663745. Epub 2016 Sep 25.
3
Plasminogen activator inhibitor-1 4G/5G gene polymorphism and primary open-angle glaucoma.
纤溶酶原激活物抑制剂-1 4G/5G基因多态性与原发性开角型青光眼
Mol Vis. 2008 Jul 4;14:1240-4.
4
Rosiglitazone and glimeperide: review of clinical results supporting a fixed dose combination.罗格列酮与格列美脲:支持固定剂量复方制剂的临床结果综述
Vasc Health Risk Manag. 2007;3(2):211-20. doi: 10.2147/vhrm.2007.3.2.211.
5
Approaches to prevention of cardiovascular complications and events in diabetes mellitus.糖尿病心血管并发症及事件的预防方法。
Drugs. 2007;67(7):997-1026. doi: 10.2165/00003495-200767070-00005.
6
Plasminogen activator inhibitor type-1 (part one): basic mechanisms, regulation, and role for thromboembolic disease.1型纤溶酶原激活物抑制剂(第一部分):基本机制、调节及其在血栓栓塞性疾病中的作用
J Thromb Thrombolysis. 2001 May;11(3):183-93. doi: 10.1023/a:1011955018052.
7
Serum insulin, proinsulin and proinsulin/insulin ratio in type 2 diabetic patients: as an index of beta-cell function or insulin resistance.2型糖尿病患者的血清胰岛素、胰岛素原及胰岛素原/胰岛素比值:作为β细胞功能或胰岛素抵抗的指标
Korean J Intern Med. 2000 Dec;15(3):195-201. doi: 10.3904/kjim.2000.15.3.195.
8
Determinants of coronary vascular disease in patients with type II diabetes mellitus and their therapeutic implications.2型糖尿病患者冠状动脉疾病的决定因素及其治疗意义。
Clin Cardiol. 1997 May;20(5):433-40. doi: 10.1002/clc.4960200506.
9
Different binding and degradation of proinsulin, insulin and insulin-like growth factor-1 (IGF-1) in cultured renal proximal tubular cells. Implications for the prolonged serum half-life of proinsulin.原胰岛素、胰岛素及胰岛素样生长因子-1(IGF-1)在培养的肾近端小管细胞中的不同结合与降解。对原胰岛素血清半衰期延长的意义。
Acta Diabetol. 1996 Jul;33(2):159-65. doi: 10.1007/BF00569428.
10
High affinity binding sites for proinsulin in human IM-9 lymphoblasts.人IM-9淋巴母细胞中胰岛素原的高亲和力结合位点。
Diabetologia. 1996 Apr;39(4):421-32. doi: 10.1007/BF00400673.